NGL FINE CHM share price has zoomed 8% and is presently trading at Rs 2,898.0.
Meanwhile, the BSE HEALTHCARE index is at 51,243.9 .
Among the top gainers in the BSE HEALTHCARE index today are GRANULES INDIA (up 4.1%) and CAPLIN POINT (up 3.8%).
J.B.Chemicals (down 3.7%) and POLY MEDICURE (down 1.7%) are among the top losers today.
Over the last one year, NGL FINE CHM has moved up from Rs 1,451.0 to Rs 2,898.0, registering a gain of Rs 1,447.0 (up 99.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 43,726.7 to 51,243.9, registering a gain of 17.2% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 117.9%), GRANULES INDIA (up 70.5%) and Aurobindo Pharma (up 62.4%).
Festive Deal: You Get Our Large Cap & Small Cap Research at Just Rs 2,950 + GST.
The BSE Sensex is at 76,569.9 .
The top losers among the BSE Sensex today are Titan (down 1.9%) and Tech Mahindra (down 1.2%). The most traded stocks in the BSE Sensex are NTPC and HDFC Bank.
In the meantime, NSE Nifty is at 23,912.6 . Titan and Bajaj Auto are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved down from 80,157.9 to 76,569.9, registering a loss of 3,588.0 points (down 4.5%).
NGL FINE CHM net profit grew 99.1% YoY to Rs 184 million for the quarter ended June 2026, compared to a profit of Rs 92 million a year ago. Net sales rose 33.6% to Rs 1,392 million during the period as against Rs 1,042 million in April-June 2025.
For the year ended March 2026, NGL FINE CHM reported 127.8% increase in net profit to Rs 481 million compared to net profit of Rs 211 million during FY25. Revenue of the company grew 36.0% to Rs 5,010 million during FY26.
The current Price to earnings ratio of NGL FINE CHM, based on rolling 12 month earnings, stands at 31.3.
Image source: Eoneren/www.istockphoto.com
Equitymaster requests your view! Post a comment on "NGL FINE CHM Gains 8%; BSE HEALTHCARE Index Down 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!